PPT-Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B

IntroductionOverview IntroductionOverview cont Importance of Prophylaxis and Limitations on Its Application in Hemophilia B Key Unmet Need in Hemophilia B Reducing Patient Burden of Disease. Nairobi, Kenya. June 24, 2013. Jim Munn, R.N., M.S.. Program Nurse Coordinator. University of Michigan HTC. Ann Arbor, MI, USA. Chair – WFH Nursing . Committee. Acknowledgement. : . Slides 20,21, 23-28 . Nairobi, Kenya. June 24, 2013. Objectives. Identify historical approaches used to treat hemophilia. Describe treatment products currently available for use in hemophilia. Distinguish classes of factor concentrates. More Than Factor Replacement Prescription. IDG. . Ugrasena. Hematology-oncology division . Child Health . Departement. of Dr. . Soetomo. Hospital - Faculty of Medicine . Airlangga. University. Gen D. June. , . 2013. Roger L. Lundblad, Ph.D.. Consultant in Biotechnology. Chapel Hill, North Carolina. http://www.lundbladbiotech.com. And Adjunct Professor, Department of Pathology,. University of North Carolina, Chapel Hill, North Carolina. Sex-linked inheritance; almost all patients male. Female carriers may have mild symptoms. Most bleeding into joints, muscles; mucosal and CNS bleeding uncommon. Severity inversely proportional to factor level. . Peterson, Owen Comer, Quaevon Anderson, and Grace Hodges. Basic Information . Grace. . Hemophilia A. Classic hemophilia. Factor VIII deficiency. Hemophilia B. Christmas disease. Factor IX deficiency. A new ambition of the World Federation of Hemophilia. WFH Guidelines for the Management of Hemophilia. All recommendations are consensus based.. Srivastava A et al. Haemophilia. 2020;26(Suppl 6):1–158. . WVNHF. Amber Tichnell, Executive Director. Hemophilia and other bleeding disorders. The human body is made up of several clotting factors – Factors 1 through 13 plus Von . Willebrand. Factor. A person can have deficiencies in any of these factors. Hemophilia A. Also known as Factor VIII Deficiency is the most common type of hemophilia. It is a disorder of your blood-clotting system. Clotting is the process which your blood changes from a liquid to a solid state. Andrew J. . Costandi. , MD, MMM . Children’s Hospital Los Angeles. USC Keck School of Medicine. Faculty Disclosures. None. Learning Objectives. Upon completion of this activity, participants will be able to:. Lec. . Dr. Abeer Abdulhadi Rashid. Introduction. . . Anemia. is . a reduction in the concentration of hemoglobin (. Hgb. ) that results in reduced oxygen. c. arrying. capacity of the blood. . Some patients with anemia may be asymptomatic initially, but eventually, the lack of oxygen to tissues results in fatigue, lethargy, shortness of breath, headache, edema, and tachycardia. . . Chelsea Marion, MD. 1,4. , Oluwaseun Odewole, MD, MPH. 2,4. , Sheila Goel, MD. 3,4. . 1. Dept. of Pediatrics, Morehouse School of Medicine, Atlanta, GA. . 2. Dept. of Family Medicine, Morehouse School of Medicine, Atlanta, GA. . Dr. S. Parthasarathy . MD., DA., DNB, MD (. Acu. ), . Dip. Diab.DCA, Dip. Software statistics . PhD (. physio. ). . Mahatma . gandhi. medical college and research institute, . puducherry. , India. Robin Reid, MD. Clinical Director, Mary M Gooley Hemophilia Center. Hematologist and Medical Oncologist, Rochester Regional Health. July . 2021. Outline. History of the Mary M Gooley Hemophilia Treatment Center.